Increased cumulative doses and appearance of hand-foot skin reaction prolonged progression free survival in sorafenib-treated advanced hepatocellular carcinoma patients
In conclusion, increased cumulative doses of sorafenib as well as the appearance of HFSR were indicators of prolonged mPFS in sorafenib-treated advanced HCC patients.
Source: The Kaohsiung Journal of Medical Sciences - Category: Universities & Medical Training Source Type: research
More News: Alopecia | Cancer & Oncology | Carcinoma | Children | Hepatocellular Carcinoma | Liver | Liver Cancer | Palliative | Skin | Study | Toxicology | Universities & Medical Training | Urology & Nephrology